Rapamycin Induces Insulin Resistance and Glucose Intolerance
D
Dr. Ben Bikman's podcast episode on September 12, 2024
Story of claim
Dr. Bikman highlights rapamycin's role in inducing insulin resistance, elevating glucose intolerance, and impacting metabolic health.
- Goal: To understand the metabolic implications of rapamycin use.
- Proof: Rapamycin use links to insulin resistance and glucose intolerance, challenging its longevity benefits.
- Nuances:
- Insulin resistance undermines longevity.
- Low insulin and glucose levels linked to longer lifespan.
- Impact on Life: Potential metabolic health challenges affecting long-term health outcomes.
Investments
- Price: Costs related to managing insulin resistance and glucose levels.
- Time: Ongoing management of metabolic health.
- Effort: Increased dietary and lifestyle focus to manage effects.
Risks
Induced insulin resistance and glucose intolerance.
Alternatives
- Diet and exercise adjustments for better metabolic health.
Get Started 🚀
- Regularly monitor blood glucose and insulin levels.
- Work with a healthcare provider to manage metabolic health.
- Consider dietary changes to support insulin sensitivity.
Brogevity AI can make mistakes. Check important info.